Behind the Scenes at the RI-MUHC Technology Platforms
Public tours followed the journey of a cancer research sample at the Glen site
The 2019 RI-MUHC Annual Report is online!
Leveraging discovery to improve human health “Across the Lifespan”
The MUHC teams up with LSU Health New Orleans to advance Usher Syndrome antisense therapy research
Researchers collaborate to treat vision loss linked to Usher thanks to a 1.74 million USD grant from the National Institutes of Health
Safe and efficient tool to reduce seniors’ medication overload
The elderly are often prescribed multiple medications for different health conditions. While some medications are needed, polypharmacy and medication overload can be costly and even harmful.
New cutting-edge cardiac MRI machine at the Glen site is a boon to patients and heart research!
The MUHC received the 3T GE SIGNA™ Premier, a flagship GE Medical Systems Cardiac Magnetic Resonance (MR) machine, on Saturday, September 21, 2019
Sepsis: testing before starting treatment is essential
Timely administration of appropriate antibiotics is essential to prevent death in patients with severe infections. Can healthcare teams “skip” drawing blood for bacterial cultures?
A close look at the progression of cells from normal to tumour
How exactly does a normal cell become a tumour?
How Salmonella tackles cellular defense mechanisms
Researchers uncover new protein that plays key role in bacterial infections
Strong criteria for diagnosing sarcopenia
Scientists propose diagnostic tools to identify, and possibly limit, the effects of sarcopenia, a disease that significantly reduces the quality of life of the aging population
Move to single-patient rooms at MUHC’s Glen site resulted in immediate, dramatic and long-lasting decrease of infection rates
Rates of colonization of two health-associated infections tumbled soon after historic hospital move